ReviewDrugs in context2020

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib.

Novin Nezamololama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.